Literature DB >> 14285295

THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES.

N CHALVARDJIAN.   

Abstract

A comparison was made of the content of heat-labile antigens 1, 2 and 3 in strains of Bordetella pertussis isolated in Toronto, and the content of the same antigens in vaccines being used in that community. Antisera were prepared in rabbits and made monospecific by absorptions. Antigens were detected by slide agglutination tests. Of the 58 strains examined, 56 contained antigens 1 and 3 but no antigen 2 was detected. Nine of these strains were isolated from children who had received a full course of vaccination and had subsequently developed pertussis. All 10 vaccines examined contained antigen 1; two, possibly four, contained no antigen 2; and seven of the 10 vaccines were weak or deficient in antigen 3. This work suggests that improved protection might be attained by the use of vaccines containing adequate amounts of all three antigens.

Entities:  

Keywords:  ANTIGENS; BORDETELLA PERTUSSIS; PERTUSSIS VACCINE

Mesh:

Substances:

Year:  1965        PMID: 14285295      PMCID: PMC1928309     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1963-09-21

2.  DEVELOPMENT OF PERTUSSIS VACCINE PRODUCTION AND CONTROL IN THE NATIONAL INSTITUTE OF PUBLIC HEALTH IN THE NETHERLANDS DURING THE YEARS 1950--1962.

Authors:  H H COHEN
Journal:  Antonie Van Leeuwenhoek       Date:  1963       Impact factor: 2.271

3.  Canada's experience with multiple antigens.

Authors:  R J WILSON
Journal:  Can J Public Health       Date:  1962-11

4.  The protective activity of components of Bordetella pertussis cell walls.

Authors:  I W SUTHERLAND
Journal:  Immunology       Date:  1963-05       Impact factor: 7.397

5.  Fluorescent antibody staining and agglutination reactions in Bordetella pertussis cultures.

Authors:  G ELDERING; W C EVELAND; P L KENDRICK
Journal:  J Bacteriol       Date:  1962-04       Impact factor: 3.490

6.  The relation between agglutinin production by pertussis vaccines and their immunising potency in mice.

Authors:  N W PRESTON; W A TE PUNGA
Journal:  J Pathol Bacteriol       Date:  1959-07

7.  Pertussis immunization in pediatric practice and in public health.

Authors:  R W PROVENZANO; L H WETTERLOW; J IPSEN
Journal:  N Engl J Med       Date:  1959-09-03       Impact factor: 91.245

8.  Serological study of Bordetella pertussis and related species.

Authors:  G ELDERING; C HORNBECK; J BAKER
Journal:  J Bacteriol       Date:  1957-08       Impact factor: 3.490

9.  Protective antigen of haemophilus pertussis.

Authors:  L PILLEMER; L BLUM; I H LEPOW
Journal:  Lancet       Date:  1954-06-19       Impact factor: 79.321

10.  STABILIZATION OF PERTUSSIS VACCINE IN THE PRESENCE OF BENZETHONIUM CHLORIDE.

Authors:  B H OLSON; G ELDERING; B GRAHAM
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

View more
  8 in total

1.  IMMUNIZATION AGAINST WHOOPING COUGH.

Authors:  A M GILL; A T OTAKI; J R DALY; J SPENCER-PEET
Journal:  Br Med J       Date:  1965-07-03

2.  Bordetella pertussis serotypes in Canada.

Authors:  S Toma; H Lo; M Magus
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

3.  The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period.

Authors:  C Bronne-Shanbury; D Miller; A F Standfast
Journal:  J Hyg (Lond)       Date:  1976-04

4.  Bordetella pertussis in the National Capital Region: prevalent serotype and immunization status of patients.

Authors:  E Rossier; F Chan
Journal:  Can Med Assoc J       Date:  1977-11-19       Impact factor: 8.262

5.  Bordetella pertussis serotypes in the United States.

Authors:  G Eldering; J Holwerda; A Davis; J Baker
Journal:  Appl Microbiol       Date:  1969-10

6.  Bordetella pertussis culture having only species factor 1.

Authors:  G Eldering; J Holwerda; J Baker
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

7.  Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.

Authors:  J Munoz; B M Hestekin
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

8.  Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen.

Authors:  R F Ross; J Munoz
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.